The livestock parasiticides market size was valued at $2,607.4 million in 2021, and is projected to reach $4,855 million by 2031, registering a CAGR of 6.7% from 2022 to 2031. The livestock parasiticides market is meant to provide the chemical substances that remove parasites other than fungi and bacteria in livestock. These chemicals are generally inert ingredients that are made in a formulation and consist of one or more than one active ingredient in it. Most of the parasiticidal have active ingredients, which have similar chemical structures and have many of the common features among them. They are grouped into different chemical classes and families as well. The importance of the livestock parasiticides has been recognized for the protection and the cure of parasitic diseases in the animal. Many key players and the companies throughout the world are coming up with various new formulations and the products in the livestock parasiticides market to remove the increasing prevalence of the foodborne diseases.
The major factors that drive the growth of the livestock parasiticides market are increasing awareness about animal healthcare worldwide. Moreover, the escalating number of livestock animals for the purpose of food production in the emerging economies is leading to rising demand for animal healthcare products. And surge in the animal healthcare expenditure for animal welfare to improve their health of livestock animals further fuels the overall livestock parasiticides market. It was also found that there was mixed impact of COVID-19 on livestock parasiticides market.
There was significant decline in the demand for animal health products. The decline in demand for livestock business primarily in clinical administrator pharmaceuticals segment was due to social distancing guidelines followed across the globe led to decrease in veterinary clinical visit. However, the rising concern about the livestock health during the pandemic ultimately led to increase in market demand.
The market in North America dominates the global livestock parasiticides market due to its well-established base of animal health industry along with rise in expenditure on animal healthcare. Whereas Asia-Pacific is expected to grow at a faster CAGR of 7.7% from 2022 to 2031, due to the presence of some of the largest animal farms such as pigs and the poultry farms in the countries such as China and India and this ultimately results in the substantial growth of the market in the region. The market in Latin America is expected to grow in upcoming future due to rise in population of livestock animals and increase in consumption of animal derived food products in the region.
A growth in preference for vegetarian food & diet coupled with the restrictions and the long approval process for livestock parasiticides for livestock animals are some of the restraints affecting the global livestock parasiticides market. The livestock parasiticides market is segmented into type, livestock, end user, and region. On the basis of type, the market is fragmented into ectoparasiticides, endoparasiticides, and endectocides. On the basis of livestock, the market is categorized into cattle, pigs, poultry, sheep, and goats. On the basis of end user, the market is bifurcated into veterinary clinics & hospitals and animal farms. Region wise, it is analyzed across North America (the U. S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, The Netherlands, Switzerland and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Thailand, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, & Africa).
The major factors that drive the growth of the livestock parasiticides market are increasing awareness about animal healthcare worldwide. Moreover, the escalating number of livestock animals for the purpose of food production in the emerging economies is leading to rising demand for animal healthcare products. And surge in the animal healthcare expenditure for animal welfare to improve their health of livestock animals further fuels the overall livestock parasiticides market. It was also found that there was mixed impact of COVID-19 on livestock parasiticides market.
There was significant decline in the demand for animal health products. The decline in demand for livestock business primarily in clinical administrator pharmaceuticals segment was due to social distancing guidelines followed across the globe led to decrease in veterinary clinical visit. However, the rising concern about the livestock health during the pandemic ultimately led to increase in market demand.
The market in North America dominates the global livestock parasiticides market due to its well-established base of animal health industry along with rise in expenditure on animal healthcare. Whereas Asia-Pacific is expected to grow at a faster CAGR of 7.7% from 2022 to 2031, due to the presence of some of the largest animal farms such as pigs and the poultry farms in the countries such as China and India and this ultimately results in the substantial growth of the market in the region. The market in Latin America is expected to grow in upcoming future due to rise in population of livestock animals and increase in consumption of animal derived food products in the region.
A growth in preference for vegetarian food & diet coupled with the restrictions and the long approval process for livestock parasiticides for livestock animals are some of the restraints affecting the global livestock parasiticides market. The livestock parasiticides market is segmented into type, livestock, end user, and region. On the basis of type, the market is fragmented into ectoparasiticides, endoparasiticides, and endectocides. On the basis of livestock, the market is categorized into cattle, pigs, poultry, sheep, and goats. On the basis of end user, the market is bifurcated into veterinary clinics & hospitals and animal farms. Region wise, it is analyzed across North America (the U. S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, The Netherlands, Switzerland and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Thailand, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, & Africa).
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the livestock parasiticides market analysis from 2021 to 2031 to identify the prevailing livestock parasiticides market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the livestock parasiticides market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global livestock parasiticides market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Ectoparasiticides
- Endoparasiticides
- Endectocides
By Livestock
- Poultry
- Sheep and goats
- Cattle
- Pigs
By End user
- Veterinary clinics and hospitals
- Animal farms
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- UK
- Italy
- Germany
- France
- Spain
- The Netherlands
- Switzerland
- Rest Of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Rest Of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
Key Market Players
- Elanco
- C. H. Boehringer Sohn AG & Co. KG.
- Zoetis
- Merck & Co., Inc.
- Virbac
- Vetoquinol
- PETIQ, LLC
- SeQuent
- Krka
- ECO Animal Health Ltd
- Ceva
- Chanelle Pharma
- Bimeda, Inc.
- Norbrook
- Kyoritsuseiyaku
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: LIVESTOCK PARASITICIDES MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Ectoparasiticides
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Endoparasiticides
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Endectocides
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK
5.1 Overview
5.1.1 Market size and forecast
5.2 Cattle
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Pigs
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Poultry
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Sheep and goats
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: LIVESTOCK PARASITICIDES MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Veterinary clinics and hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Animal farms
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: LIVESTOCK PARASITICIDES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Livestock
7.2.4 North America Market size and forecast, by End user
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Livestock
7.2.5.1.3 Market size and forecast, by End user
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Livestock
7.2.5.2.3 Market size and forecast, by End user
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Livestock
7.2.5.3.3 Market size and forecast, by End user
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Livestock
7.3.4 Europe Market size and forecast, by End user
7.3.5 Europe Market size and forecast, by country
7.3.5.1 UK
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Livestock
7.3.5.1.3 Market size and forecast, by End user
7.3.5.2 Italy
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Livestock
7.3.5.2.3 Market size and forecast, by End user
7.3.5.3 Germany
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Livestock
7.3.5.3.3 Market size and forecast, by End user
7.3.5.4 France
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Livestock
7.3.5.4.3 Market size and forecast, by End user
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Livestock
7.3.5.5.3 Market size and forecast, by End user
7.3.5.6 The Netherlands
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Livestock
7.3.5.6.3 Market size and forecast, by End user
7.3.5.7 Switzerland
7.3.5.7.1 Market size and forecast, by Type
7.3.5.7.2 Market size and forecast, by Livestock
7.3.5.7.3 Market size and forecast, by End user
7.3.5.8 Rest of Europe
7.3.5.8.1 Market size and forecast, by Type
7.3.5.8.2 Market size and forecast, by Livestock
7.3.5.8.3 Market size and forecast, by End user
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Livestock
7.4.4 Asia-Pacific Market size and forecast, by End user
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Livestock
7.4.5.1.3 Market size and forecast, by End user
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Livestock
7.4.5.2.3 Market size and forecast, by End user
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Livestock
7.4.5.3.3 Market size and forecast, by End user
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Livestock
7.4.5.4.3 Market size and forecast, by End user
7.4.5.5 Australia
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Livestock
7.4.5.5.3 Market size and forecast, by End user
7.4.5.6 Indonesia
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Livestock
7.4.5.6.3 Market size and forecast, by End user
7.4.5.7 Thailand
7.4.5.7.1 Market size and forecast, by Type
7.4.5.7.2 Market size and forecast, by Livestock
7.4.5.7.3 Market size and forecast, by End user
7.4.5.8 Rest of Asia-Pacific
7.4.5.8.1 Market size and forecast, by Type
7.4.5.8.2 Market size and forecast, by Livestock
7.4.5.8.3 Market size and forecast, by End user
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Livestock
7.5.4 LAMEA Market size and forecast, by End user
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Latin America
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Livestock
7.5.5.1.3 Market size and forecast, by End user
7.5.5.2 Middle East
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Livestock
7.5.5.2.3 Market size and forecast, by End user
7.5.5.3 Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Livestock
7.5.5.3.3 Market size and forecast, by End user
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Elanco Animal Health Incorporated
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 BOEHRINGER INGELHEIM GMBH
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Zoetis Inc
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 MERCK & CO., INC
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 VIRBAC
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 VETOQUINOL S. A.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 PETIQ, LLC
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 sequent scientific limited
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 KRKA GROUP
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 ECO ANIMAL HEALTH GROUP PLC
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 CEVA SANTÉ ANIMALE
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 CHANELLE PHARMA
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 BIMEDA ANIMAL HEALTH
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 NORBROOK
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 KYORITSU SEIYAKU CORPORATION
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Livestock Parasiticides Market,' the Livestock Parasiticides Market Size was at $2.6 billion in 2021, and is estimated to reach $4.9 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.The livestock parasiticides market is meant to provide the chemical substances that remove parasites other than fungi and bacteria in animal livestock. These chemicals are generally inert ingredients that are made in a formulation comprising of one or more than one active ingredients.
Most of the parasiticidal have active ingredients, which have similar chemical structures and have many of the common features among them. They are grouped into different chemical classes and families as well. Many key players and companies throughout the world are coming up with various new formulations and products in the livestock parasiticides market to remove the increasing prevalence of diseases among livestock. The major factors that drive the Livestock Parasiticides Market Growth are increasing regulations for preventing the spread of animal diseases as animal diseases pose threat to public health and cause damage to businesses and the economy at large.
Farmers and the government take every precaution to prevent these diseases by taking measures such as keeping animal housing clean and vaccinating livestock. The governments of various countries across the globe monitors animal health in association with a different organizations such as consumer products safety authorities, which helps them to take immediate action in the event of an outbreak of infectious disease among livestock animal, they also help in identifying the causes of animal diseases that do not normally occur in a particular region.
Thus, such initiatives by the government also help in spreading awareness among livestock farm owners and also help in joint venture programs between key players and farm owners to R&D and develop effective livestock health products thus driving the market demand. Climate seasonality and weather events such as pressure humidity, wind speed, and the direct influence of zoonotic spread. Climate change has increased the range and the number of viruses and bacteria to which animals may be exposed as well as competent vectors and the receiver species. Livestock parasiticides provide benefits for the treatment of zoonotic diseases. They can be used by veterinary physicians and hospital staff. The key players are offering livestock parasiticides and are developing value-added features such as effective sprays, dips, and collars. These rising concerns about zoonotic diseases due to the increasing number of livestock farms and the rise in demand for meat across the globe have led to Livestock Parasiticides Market Share.
Furthermore, the outbreak of the COVID-19 pandemic had a mixed impact on livestock Parasiticides Market Trends. There was a significant decline in the demand for animal health products. Some of the leading players in the animal health business around the world witnessed a decline, which is attributed to a decrease demand for animal business primarily in clinical administrator pharmaceuticals where social distancing guidelines led to a decrease in veterinary visits. However, the rising concern about pet health and the increasing adoption of pets during the pandemic ultimately led to an increase in Livestock Parasiticides Market Demand. , also, the increasing demand for home healthcare making a positive impact to the market.
The livestock parasiticides market is expected to witness significant growth, owing to a surge in demand for protein food or animal-derived food and an increase in the incidence of zoonotic and food-borne diseases globally. In addition, the increasing investments by the private players, regulations for preventing the spread of animal diseases, and rising animal health expenditures are the key drivers of the market.
The growth in demand in the livestock parasiticides market for effective drugs is the key attraction for the leading market players with huge investments in the industry. Moreover, it is one of the major drivers boosting R&D efforts in the animal health industry. At present many leading market players are focusing on R&D to develop new drugs. It was also found that globally the spending on R&D in animal healthcare is about 7 to 8% of the total revenue of individual market players. And according to the European international federation of animal health, it was found that the major players are spending about 12% of their annual sales on R&D activities. On the other hand, 6% of annual sales are invested on R&D activities by the small and medium players.
Some of the key players in the livestock parasiticides industry include Elanco animal health Incorporated, Boehringer Ingelheim Gmbh, Zoetis Inc. Merck & Co.Inc, virbac, Vetoquinol S.A., Petiq, Llc, Sequent Scientific Limited, Krka Group, Eco Animal Health Group Plc, Ceva Santé Animale, Chanelle Pharm, Bimeda Animal Health and Norbrook.
Key findings of the study
By type, the livestock parasiticides, and ectoparasiticides segment dominated the global market in 2021, and is expected to retain its dominance throughout the market forecast period.On the basis of livestock, the cattle segment accounted for a major share in the livestock parasiticides market in 2021, and is expected to grow at a significant CAGR during the forecast period.
Depending on end user, the veterinary clinics and hospitals segment accounted for a major share of the market in 2021, and is expected to grow at a significant CAGR during the forecast period.
Asia-Pacific accounted for highest market share in 2021, and is expected to grow at a significant CAGR during the forecast period.
Companies Mentioned
- Elanco
- C.H. Boehringer Sohn AG & Co. KG.
- Zoetis
- Merck & Co. Inc.
- Virbac
- Vetoquinol
- Petiq, LLC
- Sequent
- Krka
- Eco Animal Health Ltd.
- Ceva
- Chanelle Pharma
- Bimeda, Inc.
- Norbrook
- Kyoritsuseiyaku
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 290 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 2607.4 million |
| Forecasted Market Value ( USD | $ 4855 million |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
